Toronto Ottawa Heart Summit - Heart Failure Update


Program Agenda (2024)

Who should attend:

  • Cardiovascular specialists
  • Internists
  • Allied health professionals
  • Heart failure care teams
  • Cardiovascular Trainees, Residents and Fellows
  • Basic scientist interested in CV disease
  • Primary care providers


The overall goal of this symposium is to promote the exchange of existing knowledge from innovative cellular research, through translation, to foster dissemination and collaboration, leading to better cardiovascular outcomes.

Upon completion of this program participants should be able to:

  • Identify key updates, recommendations, and changes in hypertension management and treatment strategies outlined in the guidelines
  • Analyze emerging research and evidence suggesting the need for a paradigm shift in the approach to brain and heart care
  • Identify the relevant advances and highlight promising research concerning the interaction between exercise and cognition
  • Define common conditions of brain-heart related disorders and discuss therapeutic treatment options
  • Discuss the positive and negative impact of mental wellness on brain heart health
  • Recognize the interconnectedness between brain health and heart health, and understand the implications of this relationship for overall well-being
  • Review the direct and indirect mechanism of Cannabis on brain and heart function
  • Review the evolving research and evidence regarding marijuana use and its effects on brain and heart health, incorporating new findings into clinical practice to optimize patient care and outcomes
  • Recognize the importance of assessing cognitive function
  • Summarize steps for quick cognitive screening in the office setting
  • Identify best practices for the management of patients with ischemic heart disease
  • Evaluate the implications of the ORBITA-2 trial results on current clinical practice guidelines for the management of stable angina
  • Determine best treatment options for patients with Mitral and Tricuspid valve disease
  • Analyze the evolution of transcutaneous interventions for mitral and tricuspid valve disease, including the development of novel techniques and devices
  • Recognize and understand the burden of obesity and the cardiovascular impact with the utilization of novel therapies for weight reduction
  • Evaluate the implications of the STEP-HFpEF trial in patients with obesity and HFpEF in relation to the safety and efficacy
  • Review best treatment options of an integrated approach to assessment and managing psychological care in severe obesity
  • Choose optimal LDL lowering agents to reduce plaque burden in patients with CV disease
  • Evaluate how AI can Enhance Diagnosis and Prognosis through ECG Analysis
  • Identify the challenges and barriers to the adoption of AI in medicine, including data privacy concerns, regulatory issues, and integration with existing clinical workflows
  • Discuss the role of artificial intelligence (AI) in medical imaging, including image analysis, interpretation, and decision support
  • Explain cardiac dyssynchrony and options for optimal resynchronization therapy for patients with heart failure
  • Review the strengths and limitations of different devices used to detect arrhythmias
  • Evaluate the efficacy and safety of atrial fibrillation ablation procedures, based on available clinical trial data, meta-analyses, and real-world experience
  • Review various rheumatological diseases that can affect the heart and learn how to investigate and manage patients with elevated CV risks
  • Discuss the treatment strategy for patients with amyloidosis including disease modifying therapies
  • Discuss the complex phenotypic presentation of HCM and treatment options
  • Describe the emerging therapies in the management of Diabetic Kidney Disease, benefits, indications and limitations.

Last Update: May 24, 2024
* Virtual Presentation
Day 2

Friday, June 14, 2024

  SESSIONS 1 AND 2: Co-locate with Inaugural Brain Heart Interconnectome (BHI) State of the Science Summit and the Canadian Association of Cardiovascular Prevention and Rehabilitation Conference (CACPR) Meeting
7:00 Breakfast and Registration
8:00 Welcome Remarks
Drs. Peter Liu, Michelle Graham, Ruth Slack and Colin Yeung
  Session 1: Stemming the Tide of Brain & Heart
Chairs: Drs. Peter Liu and Mitchell Elkind
8:15 Cardiology trainee case presentation
Dr. Kai Yi Wu
8:20 C-CHANGE Brain Heart Guidelines
Dr. Sheldon Tobe
8:35 Brain and Heart Care: Time for a Paradigm Shift?
Dr. Mitchell Elkind
8:50 The Vascular Underpinning of Dementia
Dr. Sandra Black
9:05 Tackling the Heart-Brain Axis: Etiologies, Prevention and Intervention for Neurocognitive Deficits in Cardiovascular Diseases
Dr. Louis Bherer
9:20 Panel Discussion
9:40 Distinguished Lecture: Improving the Cardiovascular Health of the Population
Dr. Donald Lloyd-Jones*
10:15 Break
  Session 2: Mind and Heart
Chair: Dr. Peter Liu and Ruth Slack
10:45 Cardiology trainee case presentation
Dr. Veronica Chan
10:50 Psychological Well-being and Brain Heart Health
Dr. Vanessa Taler
11:05 Marijuana Use: Effect on Brain Heart Health
Dr. Hassan Mir
11:20 How to do Cognitive Screening and Why is it Important?
Dr. Peter Lin
11:35 Panel Discussion
12:00 Lunch
  Session 3: Intervention
Chairs: Drs. Jessica Forcillo and Michelle Graham
1:15 Cardiology trainee case presentation
Dr. Eliza Calin
1:20 ORBITA-2 Trial and Intervention in Stable Angina
Dr. Janine Eckstein
1:35 Multi-Arterial Revascularization
Dr. Stephen Fremes
1:50 New Avenues in Transcutaneous Mitral and Tricuspid Valve Disease
Dr. Kendra Grubb*
2:05 Panel Discussion
2:25 Break
  Session 4: Obesity/Lipids
Chair: Drs. Michael Farkouh* and Ruth McPherson
2:45 Cardiology trainee case presentation
Dr. Mehmet Onur Omaygen
2:50 Obesity
Dr. Steven Nissen*
3:05 STEP-HFpEF Trial
Dr. Mikhail Kosiborod*
3:20 Obesity and Mental Health: Helping to change Clinician and Patient Perspectives (Over 3 Decades)
Dr. Robert Dent
3:35 Lipid Optimization: Role on Plaque Burden & CV Outcomes
Dr. Ruth McPherson
3:50 Panel Discussion
4:05 Rapid Fire Oral Presentation
4:35 Refreshments & Poster Session
5:30 Adjournment
Day 3

Saturday, June 15, 2024

  THEME: Resolving 0ngoing Controversies in Cardiovascular Disease
7:00 Registration and Breakfast
8:00 Welcome Remarks
Drs. Michelle Graham and Peter Liu
  Session 5: Artificial Intelligence
Chair: Dr. Theresa Tsang* and Christopher Sun
8:10 Cardiology trainee case presentation
Dr. Yoshito Kadoya
8:15 Imaging and AI Interface
Dr. Teresa Tsang*
8:30 The Future of Patient Wearables?
Dr. Michael McGillion
8:45 Artificial Intelligence for Diagnosis & Prognosis Using ECGs: The Alberta Narrative
Dr. Sunil Kalmady
9:00 Panel Discussion
9:20 Keynote Lecture: Global Burden of Brain and Heart Conditions and Trajectory
Dr. Srinath Reddy*
10:00 Break
  Session 6: Arrhythmias and Devices
Chair: Drs. Soori Sivakumaran and Michelle Graham
10:30 Cardiology trainee case presentation
Dr. Tammy Ryan
10:35 Long-Term Outcomes of CRT for Heart Failure
Dr. Soori Sivakumaran
10:50 Device Detected Arrhythmias
Dr. Roopinder Sandhu
11:05 Atrial Fibrillation Ablation Update
Dr. Daniel Ramirez
11:20 Panel Discussion
  Session 7: Systemic Disease and the Heart
Chairs: Drs. Paula Harvey and Susanna Mak
11:40 Cardiology trainee case presentation
Dr. Bethlehem Mengesha
11:45 Cardio-Rheumatology
Dr. Paula Harvey
12:00 Amyloidosis: New Treatment Options
Dr. Ian Paterson
12:15 New and Emerging Therapies in HCM
Dr. Carolyn Ho*
12:30 Assessing Renal Risk in CV Patients: Going Beyond GFR
Dr. Philip McFarlane
12:45 Panel Discussion
1:05 Closing Remarks and Adjournment
1:20-2:00 Lunch and Career Networking

(click on a button to view an agenda)


About us

The Toronto Ottawa Heart Summit has held successful symposia for the last 26 years. Join us at our next event where we will celebrate this anniversary.

Opt-in/Opt-out of Email Lists

In compliance with anti-spam initiatives: